InvestorsHub Logo

PlentyParanoid

11/10/17 1:56 PM

#5875 RE: RodinLP #5873

What CytRx says is that cash at hand should last until the end of 2018, if the burn rate stays at 10 M$ per quaters. I believe that by then CytRx has received first installments of FDA filing related milestone payments from NantCell and good for additional year ie. until the end of 2019 when sales related milestones and royalties might kick in. They seems to be set.

knoxlube

11/10/17 8:51 PM

#5878 RE: RodinLP #5873

Yes. It makes it more challenging to invest in a company were the CEO is constantly being sued, sometimes settling, for questionable dealings and decisions and then asks SH's for their trust by voting for an equitable R/S after trying to pull a much worse one earlier. The same CEO that seems to be going out of his way to keep his own company's stock price at record lows by "locking up" critical data and info SH's need to know in order to invest with confidence. For what purpose?

I too am counting on SK's human nature to protect himself, his money, his family and go out a WINNER in BP Paradise. How long that will take? We have no idea. The SOONer the BADR! SK will ask for an increase in A/S long before CYTR needs the $$$ and tell us there will be no dilution unless absolutely necessary, etc.... I'd like to see CYTR's pps hit at least $6 after NASDAQ compliance is announced, with a SUPER CYTR PR to follow, along with a word or two from Soon on Aldox/NDA, the "Tutes" show up, and we go to $10-12. That would certainly get me believing in Santa and SK again! Just gotta BELIEVE!

All IMO. GLTY & CYTR!